A Study of Acalabrutinib Suspension to Evaluate Relative Bioavailability and Proton-pump Inhibitor Effect in Healthy Volunteers
Clinical trial NCT04435483 · COMPLETED
Trial details
- NCT number
- NCT04435483
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2020-06-26
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.